Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-24-000010

CFO & Chief Business Officer acquired 106,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Zuga Matt CFO & Chief Business Officer 2024-01-02 Grant or award +106,000 215,687 D
Derivatives
Zuga Matt CFO & Chief Business Officer 2024-01-02 Grant or award · Employee Stock Option (right to buy) +159,000 159,000 D
Loading xslF345X05/wk-form4_1704403210.xml…